Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity.

Source:http://linkedlifedata.com/resource/pubmed/id/21123183

J. Biol. Chem. 2011 Feb 11 286 6 4703-17

Download in:

View as

General Info

PMID
21123183